HDACi - Targets beyond chromatin

被引：130

作者：

Buchwald, Marc ^{[1
]}

Kraemer, Oliver H. ^{[1
]}

Heinzel, Thorsten ^{[1
]}

机构：

[1] Univ Jena, CMB, Inst Biochem & Biophys, D-07745 Jena, Germany

来源：

CANCER LETTERS | 2009年 / 280卷 / 02期

关键词：

Acetylation; Proteasomal degradation; STATs; NF-kappaB; Signaling crosstalk; NF-KAPPA-B; HISTONE-DEACETYLASE INHIBITORS; NECROSIS-FACTOR-ALPHA; PROTEASOME INHIBITOR; PROTEIN-KINASE; VALPROIC ACID; CANCER-CELLS; IFN-GAMMA; TRANSCRIPTIONAL ACTIVATION; STIMULATED TRANSCRIPTION;

D O I：

10.1016/j.canlet.2009.02.028

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Histone deacetylases (HDACs) play an important role in gene regulation. Inhibitors of HDACs (HDACi) are novel anti-cancer drugs, which induce histone (hyper-) acetylation and Counteract aberrant gene repression. On the other hand, HDACi treatment can also result in decreased gene expression, and targeting HDACs affects more than chromatin. Recently, HDACi were shown to evoke non-histone protein acetylation, which can alter signaling networks relevant for tumorgenesis. Furthermore, HDACi can promote the degradation of (proto-) oncoproteins. Here, we summarize these findings and discuss how these substances could be beneficial for the treatment and prevention of human ailments, such as cancer and unbalanced immune functions. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

引用

页码：160 / 167

页数：8

共 87 条

[71] Acetylation-dependent signal transduction for type I interferon receptor [J].

Tang, Xiaoli ;

Gao, Jin-Song ;

Guan, Ying-Jie ;

McLane, Katya E. ;

Yuan, Zheng-Long ;

Ramratnam, Bharat ;

Chin, Y. Eugene .

CELL, 2007, 131 (01) :93-105

[72] Acetylation is indispensable for p53 activation [J].

Tang, Yi ;

Zhao, Wenhui ;

Chen, Yue ;

Zhao, Yingming ;

Gu, Wei .

CELL, 2008, 133 (04) :612-626

[73] Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP [J].

Vervoorts, J ;

Lüscher-Firzlaff, JM ;

Rottmann, S ;

Lilischkis, R ;

Walsemann, G ;

Dohmann, K ;

Austen, M ;

Lüscher, B .

EMBO REPORTS, 2003, 4 (05) :484-490

[74] Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation [J].

Wang, R ;

Cherukuri, P ;

Luo, JY .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (12) :11528-11534

[75] Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-κB activation [J].

Wang, YJ ;

Wu, TR ;

Cai, SY ;

Welte, T ;

Chin, YE .

MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (13) :4505-4512

[76] NF-κB2 p100 is a pro-apoptotic protein with anti-oncogenic function [J].

Wang, YQ ;

Cui, HJ ;

Schroering, A ;

Ding, JL ;

Lane, WS ;

McGill, G ;

Fisher, DE ;

Ding, HF .

NATURE CELL BIOLOGY, 2002, 4 (11) :888-893

[77] Histone deacetylase 3 (HDAC3) and other class IHDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer [J].

Wilson, AJ ;

Byun, DS ;

Popova, N ;

Murray, LB ;

L'Italien, K ;

Sowa, Y ;

Arango, D ;

Velcich, A ;

Augenlicht, LH ;

Mariadason, JM .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (19) :13548-13558

[78] Histone deacetylase inhibitors: molecular mechanisms of action [J].

Xu, W. S. ;

Parmigiani, R. B. ;

Marks, P. A. .

ONCOGENE, 2007, 26 (37) :5541-5552

[79] Histone deacetylase inhibitors induce the degradation of the t(8;21) fusion oncoprotein [J].

Yang, G. ;

Thompson, M. A. ;

Brandt, S. J. ;

Hiebert, S. W. .

ONCOGENE, 2007, 26 (01) :91-101

[80] Lysine acetylation: Codified crosstalk with other posttranslational modifications [J].

Yang, Xiang-Jiao ;

Seto, Edward .

MOLECULAR CELL, 2008, 31 (04) :449-461

← 1 2 3 4 5 6 7 8 9 →